Bentham Science Publishers
Bentham Science Publishers is a major publisher of more than 100 peer-reviewed science, technology and medical (STM) journals, along with a rapidly growing collection of eBooks. Since 1993, Bentham Science Publishers has been catering to the information needs of the pharmaceutical, engineering, biomedical and medical research community.781 - 800 of 1969 results
-
-
From Knowledge Networks to Biological Models
Biological Models
More LessMost findings about molecular interactions and cellular regulatory events are published in peer-reviewed scientific literature in the form of scientific jargon. The computerized text-mining algorithms are used to convert free grammar of human language into a set of formalized relationships between biological concepts in order to use this wealth of information. The compendium of such interactions extracted from an entire set of biomedical literature is a called knowledge network. Knowledge networks are the first step in the process of digitizing molecular biological knowledge. The next step is building molecular models depicting principal molecular events that govern various biological processes. Data mining in knowledge networks is the essence of building new biological models. The purpose is to elucidate major pathways of information flow through a molecular physical interaction network that happens during a disease, a cell process or an experiment. Such models contain key proteins involved in the process and can be used for prioritizing disease targets, for understanding of drug action and prevention of drug-induced toxicities, for analysis of patient predispositions and design of personalized therapies, for design of diagnostic biomarkers and analysis of patient molecular data. This e-book contains detailed examples illustrating the path to the digital biology and computerized drug development for personalized medicine. It provides conceptual principals for building biological models and for applying the models to make predictions relevant for drug development and translational medicine.
The e-book will also be useful for researchers who use high-throughput technologies for molecular profiling of disease and drug action. It provides examples for analysis of gene expression microarrays to infer biological models, to find biomarkers for drug response and for applications of high-throughput molecular profiling technologies for personalized medicine. Scientists in academia, in pharmaceutical industry as well as graduate students will benefit from reading this book. The illustrations from the book can also be readily used in taught courses for molecular biology and pharmacology.
-
-
-
From Microbe to Man
Biological Responses in Microbes, Animals, and Humans upon Exposure to Artificial Static Magnetic Fields
More LessSome arrangements and structures of permanent magnets are hypothesized to exert measurable physiological and pathological effects on living tissues when exposed to the resultant electromagnetic field. From Microbe to Man: Biological responses to artificial static magnetic field-exposure explores the effects of such arrangements based on this hypothesis.
The book begins with an explanation of the mechanisms of artificial static magnetic fields (SMFs). This is followed by sequential sections presenting the effects of SMF exposure on living organisms backed by thorough experimental studies (on microbial, animal and human trials). In conclusion, the work reveals the positive nature of SMF treatment and shows that this is indeed a viable alternative to invasive treatment in the case of a number of both acute and chronic conditions, such as stomatological pain and osteoporosis.
From Microbe to Man: Biological responses to artificial static magnetic field-exposure is aimed chiefly at medical professionals and the research community studying alternatives to conventional pain medicine and physiotherapy. However, laypeople interested in non-invasive medical treatment options can also benefit from the easy-to-read layout of the contents of this volume.
-
-
-
From SARS-CoV to MARS-CoV
Genetic Diversity of Coronaviruses: Volume 1
More LessGenetic Diversity of Coronaviruses (Volume 1) provides a comprehensive analysis of the genetic mutations and host interactions across three major coronavirusesSARS-CoV, MERS-CoV, and SARS-CoV-2. This volume explores the evolutionary history, mutations, and emerging variants of these viruses, with a focus on understanding how they adapt to different hosts. The book is organized into three parts: Part I covers SARS-CoV, detailing its genetic mutations, host genetic diversity, and new variants. Part II focuses on MERS-CoV, offering insights into mutations and host adaptations. Part III addresses SARS-CoV-2, discussing its evolving variants and the role of host proteins. The book also discusses the connections between coronaviruses and neurological, epigenetic, and AI-related issues.
Key Features:
- In-depth analysis of genetic mutations in coronaviruses.
- Exploration of host genetic diversity and virus adaptation.
- Insight into emerging variants of SARS-CoV, MERS-CoV, and SARS-CoV-2.
- Examination of host proteins' role in viral infections.
- Discussion on the impact of AI and epigenetics on coronavirus research.
-
-
-
From Semiclassical Semiconductors to Novel Spintronic Devices
More LessDramatic developments in developing semiconductor device technology and nanotechnologies over the last decades has placed increasing demands on the fabrication and design of new electronic devices, It is now necessary to implement nanoscale gate geometries to achieve the highest performance standards in new devices. The need to understand and model the operation of nano-devices is, therefore, fundamental to future development and optimal design.
From Semiclassical Semiconductors to Novel Spintronic Devices explains research related to new spintronic devices. This E-book: reports unique results on fabrication and the quite uncommon performance of Si-based solar cells with novel contacts chemically deposited on traditionally prepared semiconductor parts of the solar cell, details the mechanism behind efficient solar radiation conversion and the thermodynamics involved in theory and practice, discusses photonic condensate and relic radiation - exotic topics for theoretical astrophysics which also present possible power tools for achieving highly efficient energy conversion.
This e-book is a useful review on the latest achievements in spintronic technology, characterization methods and nanoscaled active elements modeling for novel device design and applications The text within this e-book serves as a handy resource for graduate and PhD students as well as for professionals interested in the field of semiconductor device technology and modeling as well as spintronics.
-
-
-
From Taboo to Wellness: The Facts behind Menopause
Medicine Demystified: Volume 3
More LessMenopause is a significant milestone in a woman's life, marking the end of fertility and the start of a new phase. However, it can also bring many physical and emotional symptoms, such as hot flashes, mood changes, and a higher risk of osteoporosis and heart disease. Because of these issues, dealing with menopause can be a challenge.
From Taboo to Wellness: The Facts behind Menopause is an informative guide to menopause. It provides clarity and accessibility for anyone interested in understanding the topic, and wants to deconstruct any myths that surround it with facts. From symptoms to treatments, this book covers everything you need to know about menopause in an engaging and easy-to-understand way.
Written with the general reader in mind, this book explores the science behind menopause, as well as the male andropause and how it differs from the female experience. With insights into Hormone Replacement Therapy (HRT) and future treatments using stem cells, it gives a comprehensive understanding of the options for managing menopause. But that's not all - the book also delves into the fascinating world of menopause in the animal kingdom, offering a unique perspective on how different species experience hormonal changes caused by this life-changing event.
-
-
-
Frontiers in Anti-Cancer Drug Discovery: Volume 1
More Less"Frontiers in Anti-Cancer Drug Discovery" is an eBook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
-
-
-
Frontiers in Anti-Cancer Drug Discovery: Volume 10
More LessFrontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews relevant to all areas of rational drug design and drug discovery including medicinal chemistry,in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The tenth volume of the series features chapters covering the following topics:
- Challenges in the Management of Hepatoblastoma
- The Emerging Role of Monocarboxylate Transporter-1 in Cancer
- In-vitro Anti-Proliferative Assays and Techniques Used in Pre-Clinical Anti-Cancer Drug Discovery
- Recent Advances in the Development of Mesoporous Anti-Cancer Drug Nanocarriers
- Polyphenols and Cancer
- Glioblastoma Multiforme
- Cutting Edge Targeting Strategies Utilizing Nanotechnology in Breast Cancer Therapy
-
-
-
Frontiers in Anti-Cancer Drug Discovery: Volume 11
More LessFrontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews relevant to all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The eleventh volume of the series focuses on reviews on targeted therapies and drug delivery systems. This volume covers the following topics:
- PI3K/Akt/mTOR Pathway in Acute Lymphoblastic Leukemia Targeted Therapies
>- Polymeric Nanomedicines in Treatment of Breast Cancer: Review of Contemporary Research
>- Treatment of Lung Cancer in the New Era
>- Oral Administration of Cancer Chemotherapeutics Exploiting Self-Nanoemulsifying Drug Delivery System: Recent Progress and Application
>- Targeting Approaches for the Diagnosis and Treatment of Cancer
-
-
-
Frontiers in Anti-Cancer Drug Discovery: Volume 12
More LessFrontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews relevant to all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
This volume of the series focuses on reviews of treatments derived from natural sources (cannabinoid-based medicines and turmeric), immunotherapy, biomarkers for glioblastoma and some new drug targets for anti-cancer treatment.
The reviews included in this volume are:
- Cannabinoid-Based Anticancer Strategies:
- The Beneficial Effects of Turmeric and Its Active Constituent in Cancer Treatment
- Immunotherapy Approaches Focusing on Cancer Stem Cells
- Immunotherapy for the Treatment of Hepatocellular Carcinoma
- Role of Biomarkers in Developing Therapies for Glioblastoma Multiforme
- Poly (ADP-ribose) Polymerases as New Drug Targets in Cancer Treatment
-
-
-
Frontiers in Anti-Cancer Drug Discovery: Volume 2
More LessFrontiers in Anti-Cancer Drug Discovery is an Ebook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
-
-
-
Frontiers in Anti-Cancer Drug Discovery: Volume 3
More LessFrontiers in Anti-Cancer Drug Discovery is an Ebook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery, including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The Ebook series is essential reading for all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
-
-
-
Frontiers in Anti-Cancer Drug Discovery: Volume 4
More LessFrontiers in Anti-Cancer Drug Discovery is an Ebook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery, including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The Ebook series is essential reading for all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
-
-
-
Frontiers in Anti-Cancer Drug Discovery: Volume 5
More Less"Frontiers in Anti-Cancer Drug Discovery" is an Ebook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The fifth volume of the series features chapters on the following topics:
-Nutraceuticals and natural food products for cancer treatment
-Pharmacogenomics in Anti-cancer treatment
-Cancer stem cells
-Potassium channel targeting for brain tumor treatment
-Sorafenib in the management of hepatocellular carcinoma
and more.
-
-
-
Frontiers in Anti-Cancer Drug Discovery: Volume 6
More LessFrontiers in Anti-Cancer Drug Discovery is an eBook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The sixth volume of the series features chapters on several topics including:
- Monocarboxylate transporters as anti-cancer drug targets
- Interferon α-2b treatment for hepatocellular carcinoma
- Anthracyclines in cancer therapy
- Magnetosomes and tumor therapy
…and more.
-
-
-
Frontiers in Anti-Cancer Drug Discovery: Volume 7
More LessFrontiers in Anti-Cancer Drug Discovery is an eBook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The seventh volume of the series features chapters covering the following topics:
- Malignant pleural mesothelioma
- Colorectal cancer therapy
- Drugs for treating pancreatic cancer
- Adjuvant endocrine therapy for early breast cancer
- Cyclin E and its potential use for liver cancer prognosis and therapy
-
-
-
Frontiers in Anti-Cancer Drug Discovery: Volume 8
More LessFrontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest and the most important advances in anti-cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. Each volume is devoted to the major advances in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The eighth volume of the series features chapters covering the following topics:
- T cells in gastrointestinal cancers
- The pharmacology of adjudin – a male contraceptive with anti-cancer properties
- Manipulating the tumor microenvironment
- Treatment of hepatocellular carcinoma
- Gold-based compounds as potential anti-cancer drug candidates
- Oral nanostructure drug delivery for anti-cancer treatment
-
-
-
Frontiers in Anti-Cancer Drug Discovery: Volume 9
More LessFrontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews relevant to all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The ninth volume of the series features chapters covering the following topics:
- New research on the therapeutic intervention of cancer and cancer drug delivery
- Dabrafenib usage in melanoma therapy
- Targeting autophagy in cancer therapy
- Pro-apoptotic and anti-telomerase activity of naturally occurring compounds
- CDK inhibitors
- Oral nanostructure drug delivery for anti-cancer treatment
-
-
-
Frontiers in Anti-Infective Agents: Volume 5
More LessAnti-infective agents are a distinct class of pharmacologically important molecules that has served mankind in different capacities to combat life-threating pathologic conditions. They include antibacterial, antifungal, antiviral, antituberculosis, antimalarial and urinary anti-infective agents. However, evolutionary changes, adaptations and development of pathogenic microorganisms strains the therapeutic efficacy of these drugs thus limiting their clinical utility over the years.
Frontiers in Anti-Infective Agents Volume 5 is a collection of notable research efforts, successful anti-infective drug development programmes and a comprehensive overview of the successes and failures of recent clinical trials in this domain. The volume covers interesting topics: 1) the treatment of acute wounds with the vikut® formula, 2) anti-infective treatment of ocular diseases and 3) sars-cov vaccine development and antimicrobial therapy for SARS symptoms. A chapter summarizing recent anti-infective approaches rounds up the contents of this volume.
This volume is a timely reference for postgraduate scholars and researchers seeking updates in specific areas of anti-infective drug development. Allied healthcare professionals (clinical and public healthcare professionals) can also benefit from the information presented within.
-
-
-
Frontiers in Anti-Infective Agents: Volume 6
More LessAnti-infective agents are a distinct class of pharmacologically important molecules that have served mankind in different capacities to combat life-threatening pathological conditions. They include antibacterial, antifungal, antiviral, antituberculosis, antimalarial, and urinary anti-infective agents. However, evolutionary changes, adaptations, and the development of new strains of pathogenic microorganisms have reduced the therapeutic efficacy of existing drugs, thus, limiting their clinical utility over the years.
Frontiers in Anti-Infective Agents Volume 6 is a collection of notable research efforts, successful anti-infective drug development programs, and a comprehensive overview of successful and unsuccessful clinical trials conducted in this domain. This volume continues from the last one with interesting reviews on 1) "Reverse Vaccinology" for vaccination design using computational data to identify vaccine targets, 2) leptospirosis, 3) phage therapy for bacterial infections, 4) quorum sensing inhibitors from natural products, and 5) nitrogen and oxygen-based heterocyclic compounds that can act as anti-infective agents. The volume, therefore, covers a range of frontier topics on anti-infective research and development.
This compilation is a timely reference for postgraduate scholars and researchers seeking updates in specific areas of anti-infective drug development. Allied healthcare professionals (clinical and public healthcare professionals) can also benefit from the information presented within.
-
-
-
Frontiers in Anti-Infective Drug Discovery: Volume 10
More LessFrontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
The tenth volume of this series features 4 reviews on the following topics:
-Pharmacotherapy of Posterior Segment Ocular Infections
-Discovery and Development of Antimalarial Drug-Resistance Reversal Agents
-Omics Technologies and Anti-Infective Drug Discovery
-Possible Cutaneous Adverse Effects of Anti-Infective Vaccinations
-